Atqah Abdul Wahab1, Saad J Taj-Aldeen2, Anna Kolecka3, Mei ElGindi4, Jonathan S Finkel4, Teun Boekhout5. 1. Departments of Pediatrics, Hamad Medical Corporation, Doha, PO Box 3050, Qatar; Weill Cornell Medical College, Doha, Qatar. Electronic address: atiqaaw@yahoo.com. 2. Microbiology Division, Laboratory of Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar. 3. CBS Fungal Biodiversity Center, Utrecht, the Netherlands. 4. Department of Biological Sciences, Carnegie Mellon University in Qatar, Doha, Qatar. 5. CBS Fungal Biodiversity Center, Utrecht, the Netherlands; Department of Internal Medicine and Infectious Diseases, University Medical Center, Utrecht, the Netherlands; Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Institute of Dermatology and Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China; Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Abstract
OBJECTIVES: We identified Candida spp isolated from lower respiratory tract secretions obtained from cystic fibrosis (CF) patients, by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), with the aim of determining the most prevalent causative agent. We also sought to determine their adhesive properties in order to understand their biology related to CF. METHODS: Twenty-five clinical samples were collected from a cohort of 20 CF patients. Twenty-six isolates of Candida spp were isolated and identified by MALDI-TOF MS method. Adherence assays were performed using the Fluxion BioFlux 200, a flow apparatus that allows for the visualization of adhering cells. RESULTS: MALDI-TOF MS analysis revealed C. dubliniensis to be the most prevalent species (n=18, 69%), followed by C. albicans (n=4), C. tropicalis (n=3), and C. glabrata (n=1). C. dubliniensis showed the strongest adherence under constant flow when compared to the other species of Candida. In the majority of cases, C. dubliniensis was isolated in combination with Pseudomonas aeruginosa and Staphylococcus aureus. C. dubliniensis appears to be able to survive in the CF lung and coexist with bacteria. CONCLUSIONS: The data presented here show that the presence of C. dubliniensis in the lower airways of CF patients may be related to increased adherence properties.
OBJECTIVES: We identified Candida spp isolated from lower respiratory tract secretions obtained from cystic fibrosis (CF) patients, by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), with the aim of determining the most prevalent causative agent. We also sought to determine their adhesive properties in order to understand their biology related to CF. METHODS: Twenty-five clinical samples were collected from a cohort of 20 CFpatients. Twenty-six isolates of Candida spp were isolated and identified by MALDI-TOF MS method. Adherence assays were performed using the Fluxion BioFlux 200, a flow apparatus that allows for the visualization of adhering cells. RESULTS: MALDI-TOF MS analysis revealed C. dubliniensis to be the most prevalent species (n=18, 69%), followed by C. albicans (n=4), C. tropicalis (n=3), and C. glabrata (n=1). C. dubliniensis showed the strongest adherence under constant flow when compared to the other species of Candida. In the majority of cases, C. dubliniensis was isolated in combination with Pseudomonas aeruginosa and Staphylococcus aureus. C. dubliniensis appears to be able to survive in the CF lung and coexist with bacteria. CONCLUSIONS: The data presented here show that the presence of C. dubliniensis in the lower airways of CFpatients may be related to increased adherence properties.
Authors: Paula Volpato Sanitá; Ana Cláudia Pavarina; Lívia Nordi Dovigo; Ana Paula Dias Ribeiro; Mariana Carvalho Andrade; Ewerton Garcia de Oliveira Mima Journal: Lasers Med Sci Date: 2017-11-13 Impact factor: 3.161
Authors: Lindsay A Petty; Alexander J Gallan; Jordan A Detrick; Jessica P Ridgway; Jeffrey Mueller; Jennifer Pisano Journal: Mycopathologia Date: 2016-06-24 Impact factor: 2.574
Authors: Giovanni Rodríguez-Leguizamón; Alessandro Fiori; Luisa F López; Beatriz L Gómez; Claudia M Parra-Giraldo; Arley Gómez-López; Carlos F Suárez; Andrés Ceballos; Patrick Van Dijck; Manuel A Patarroyo Journal: BMC Microbiol Date: 2015-10-05 Impact factor: 3.605
Authors: Farhana Alam; Dominic Catlow; Alessandro Di Maio; Jessica M A Blair; Rebecca A Hall Journal: J Antimicrob Chemother Date: 2020-04-01 Impact factor: 5.790